Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 42.2B | 34.1B | 33.3B | 34.0B |
Cost of revenue | 22.3B | 18.1B | 18.3B | 18.3B |
Gross profit | 19.8B | 16.0B | 15.0B | 15.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.0B | 7.7B | 7.8B | 7.6B |
Operating income | 8.1B | 4.6B | 3.7B | 4.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 893.9M | 962.5M | 937.8M | 965.4M |
Other income expense | — | — | — | — |
Pretax income | 7.1B | 3.7B | 2.8B | 3.4B |
Tax provision | 1.8B | 976.2M | 822.4M | 917.6M |
Net income | 5.3B | 2.7B | 2.0B | 2.5B |
Basic EPS | — | 9.2 | 6.8 | 8.5 |
Diluted EPS | — | 9.2 | 6.8 | 8.5 |
Basic average shares | — | 296.3M | 296.6M | 296.4M |
Diluted average shares | — | 296.3M | 296.6M | 296.4M |
EBITDA | 9.9B | 6.6B | 5.7B | 6.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |